Selective Inhibitors of Monoamine Oxidase. 2. Arylamide SAR

Journal of Medicinal Chemistry

Volumn 37, Issue 13, 1994, Pages 2085-2089

  Harfenist, Morton ^a,b   Joyner, Charles T ^a   Mize, Patrick D ^a,d   White, Helen L ^a,c  

^a Burroughs Wellcome Co   (United States)

^b Division of Organic Chemistry   (United States)

^c Divisions of Pharmacology ^*  (United States)

^d Royal Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MONOAMINE OXIDASE INHIBITOR;

ARTICLE; ENZYME INHIBITION; ENZYME SPECIFICITY; STRUCTURE ACTIVITY RELATION;

ACETAMIDES; ANIMAL; ANTIDEPRESSIVE AGENTS; BINDING, COMPETITIVE; BRAIN; CHROMATOGRAPHY, THIN LAYER; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RATS; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0027980306     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00039a021     Document Type: Article

References (15)

1. Harfenist, M.; McGee, D. P. C.; White, H. L. A Selective, Reversible, Competitive Inhibitor of Monoamine Oxidase A Containing No Nitrogen, with Negligible Potentiation of Tyramine-Induced Blood Pressure Rise. J. Med. Chem. 1991, 34, 2931.
2. Johnston, J. P. Some Observations Upon a New Inhibitor of Monoamine Oxidase in Brain Tissue. Biochem. Pharmacol. 1968, 17,1285-1297.
3. Squires, R. F. Additional Evidence for the Existence of Several Forms of Mitochondrial Monoamine Oxidase in the Mouse. Biochem. Pharmacol. 1968, 17, 1401-1409.
4. Bach, A. W. J.; Lan, N. C.; Johnson, D. L.; Abell, C. W.; Bembenek, M. E.; Kwan, S.-W.; Seeburg, P. H.; Shih, J. C. cDNA Cloning of Human Liver Monoamine Oxidase A and B: Molecular Basis of Differences in Enzymatic Properties. Proc. Natl. Acad. Sci. U.S.A. 1988,85, 4934-4938.
5. O'Carroll, A. M.; Anderson, M. C.; Tobbia, I.; Phillips, J. P.; Tipton, K. F. Determination of the Absolute Concentrations of Monoamine Oxidase A and B in Human Tissues. Biochem. Pharmacol. 1989, 38, 901-905.
6. White, H. L.; Stine, D. K. Characterization of Active MAO A and B Sites by Various Biochemical Separation Techniques. Int. Congr. Ser.-Excerpta Med. 1982, 564 (Monoamine Oxidase), 62-73.
7. Meszaros, L. A. The Biochemistry of Stress. CHEMTECH 1988,18, 22-25.
8. Kyburz, E. New Developments in the Field of MAO Inhibitors. Drug News Perspect. 1990, 3, 592-599.
9. Murphy, D. L.; Llpper, S.; Picket, D.; Jimerson, D.; Cohan, R. M.; Garrick, N. A.; Alternan, I. S.; Campbell, I. C. Selective Inhibition of Monoamine Oxidase Type A: Clinical Antidepressant Effects and Metabolic Changes in Man. In Monoamine Oxidase Inhibitors—The State of the Art; Youdin, M., Paykel, E., Eds.; John Wiley & Sons: New York, 1981; pp 189-205.
10. Harfenist, M. Prevention of Ames Test Mutagenicity by Chemical Modification in a Series of Monoamine Oxidase Inhibitors. J. Med. Chem. 1980, 23, 825-827.
11. Sanchez-Marin, J.; Orti, E.; Aullo, J. M.; Tomas, F. Molecular Associations Between Lumiflavine and Some Beta-Carbolines. THEOCHEM 1985,21, 21-27.
12. Lessen, W.; Stratius, F. III. Kapitel. TetrazotsSure. 1. Benzenyltetrazotsaure. Justus Liebigs Ann. Chem. 1897, 298, 91.
13. Hodson, H. F.; Batchelor, J. F. U.S. Patents 4,012,499 (March 15, 1977) and 4,103,015 (July 25, 1978).
14. White, H. L.; Glassman, A. T. Multiple Binding Sites of Human Brain and Liver Monoamine Oxidase: Substrate Specificities, Selective Inhibitions, and Attempts to Separate Enzyme Forms. J. Neurochem. 1977, 29, 987-997.
15. White, H. L.; Stine, D. K. Selective Effects of Proteases and Phospholipase A2 on Monoamine Oxidases A and B of Human Brain and Liver. J. Neurochem. 1984, 42, 1743-1751.